Study of Treatment for HPV16+ ASC-US or LSIL
Study of Treatment for HPV16+ ASC-US or LSIL
Recruiting · NCT03913117 · Registry updated 2026-05-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Treatment for HPV16+ ASC-US or LSIL | Atypical Squamous Cells of Undetermined Significance, Atypical Squamous Cells of the Cervix, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Morphological and Microscopic Findings, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, cervix disorder, dysplasia of cervix, female reproductive system disorder, neoplasm, precancerous condition, uterine disorder | Recruiting | Phase 1 | 2026-05-15 | NCT03913117 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Johns Hopkins University | 579 |
| University of Alabama at Birmingham | 467 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins University | Baltimore | United States | 13 |
| UAB | The University of Alabama at Birmingham | Birmingham | United States | 1 |